Pr. Harald Hampel Pr. Harald Hampel

A presentation by Prof. Harald Hampel, Chair Holder (February 2014)
Finding new Alzheimer's biomarkers for an earlier diagnosis and therapy
The recently evidenced existence of a silent stage of the disease, with no clinical symptoms expressed, yet biological markers observable, creates opportunities for improving and accelerating diagnoses. The reasonable hope of treatment in a near future urges the need for enabling diagnoses of Alzheimer at a totally asymptomatic stage, particularly for individuals nearing conversion state - when Alzheimer's effects will become evident.
Prof. Hampel and his multi-disciplinary research team in Paris endeavours to characterize the full disease "roadmap" in the brains of living people with all available biological indicators to provide effective early solutions for diagnosis and therapy for affected patients.
Discover research projects related to the topic
Mécénat des Mutuelle
France
CLIMABRAIN: Impacts of Extreme Weather on the Most Vulnerable Living with Alzheimer's disease
In the context of the increase in extreme weather events due to climate change, the project led by Tarik Benmarhnia... Read more

Tarik
BENMARHNIA
Institut National de la Santé et de la Recherche Médicale
Chronic & Non-communicable Diseases
Medical Treatment & Drug Development
AXA Project
France
Pain Pediatric & Elderly AXA Research Lab (PEARL)
Cutaneous neuropathic pain is a highly debilitating chronic condition, characterized by persistent sensations of burning, tingling, or hypersensitivity. It disproportionately... Read more
Celine
GRECO